Profit Or Loss [Abstract]

ABIONYX Pharma - Filing #2813091

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
5 252 EUR
675,000 EUR
Other gains (losses)
23,000 EUR
37,000 EUR
Profit (loss) from operating activities
4 109 EUR
5 952 EUR
Finance income
165,000 EUR
307,000 EUR
Finance costs
262,000 EUR
177,000 EUR
Profit (loss)
4 206 EUR
4 206 EUR
5 822 EUR
5 822 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
15.00
23.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
15.00
23.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.